FDA-approved branded versions include Mounjaro (approved for type 2 diabetes) and Zepbound (approved for chronic weight management)
Novo Nordisk and Eli Lilly have both invested in regional supply chains and partnerships with local distributors to improve access
Prescription GLP-1 medications are engineered to enhance or mimic this hormone's activity in a sustained, predictable way
When directly compared with dulaglutide , an established GLP-1 agonist, retatrutide produced greater improvements in HbA1c, body weight and body-fat percentage, while maintaining a similar safety profile
Study Design TRIUMPH-1 (NCT05929066) was a randomized, double-blind, placebo-controlled trial that tested weekly subcutaneous retatrutide at 4 mg, 9 mg, and 12 mg against placebo over 80 weeks
attempting to reconstitute or self-administer this unlicensed compound at home is unsafe and not endorsed by any UK regulatory body